Brucella lipopolysaccharides induce cyclooxygenase-2 expression in monocytic cells

Area of Science:

• Immunology
• Microbiology

Background:

• Human brucellosis involves acute and chronic inflammation with granuloma formation.
• Lipopolysaccharide (LPS) is a key component of Gram-negative bacteria, known to elicit inflammatory responses.

Purpose of the Study:

• To compare the pro-inflammatory effects of smooth lipopolysaccharide from Brucella (S-LPS) with LPS from Escherichia coli.
• To investigate the induction of cyclooxygenase-2 (COX-2), monocyte chemoattractant protein-1 (MCP-1), and nuclear factor kappa B (NF-kappa B) activation by these LPS types.

Main Methods:

• Stimulation of immune cells with varying concentrations of Brucella S-LPS and E. coli LPS.
• Measurement of COX-2 expression, MCP-1 production, and NF-kappa B activation.

Main Results:

• Brucella S-LPS induced COX-2 expression and MCP-1 production, but with lower potency than E. coli LPS.
• At concentrations above 1 microg/ml, both LPS types induced comparable effects, including NF-kappa B activation.
• These findings help explain inflammatory events and granuloma formation in Brucella infections.

Conclusions:

• Brucella LPS contributes to the inflammatory profile of brucellosis.
• The differential potency of LPS may influence the distinct inflammatory characteristics of Brucella infections compared to E. coli infections.
• Understanding LPS activity is crucial for explaining monocyte recruitment and granuloma formation in brucellosis.